MDx-Chex™ for BCID2 Quality Control to evaluate the entire analytical process of the
BCID2 Panel Assay for Sepsis

MDx-Chex for BCID2 is a first-of-its-kind quality control designed to meet the standards for verifying the performance of sample-to-result molecular tests for sepsis.MDx-Chex for BCID2 can be used for assay verification, to track lot-to-lot performance of tests and to reduce the occurrence of incorrect results due to instrument or assay failures.

Provided in a comprehensive and easy-to-use format, MDx-Chex for BCID2 evaluates the entire analytical process of the test, including cell lysis, DNA extraction, purification and removal of PCR inhibitors, as well as qPCR amplification, detection and analysis.

The control kit contains 43 bacteria, yeasts and antimicrobial resistance gene targets packaged in two separate vials, one for Gram (-) bacteria and one for the Gram (+) bacteria and yeasts, covering targets commonly tested for in molecular sepsis tests.

The microorganisms are intact, inactivated and suspended in a matrix of stabilized red blood cells, white blood cells and blood culture media components, which is designed to challenge the lysis and purification processes just like a patient sample.

Pack size 1 Gram (–) bacteria and 1 Gram (+) bacteria vial, 5 run capacity